Chikungunya
| Chikungunya | |
|---|---|
| Rash from chikungunya[1][2] | |
| Pronunciation |
|
| Specialty | Infectious disease |
| Symptoms | Fever, joint pain, headache, muscle pain, joint swelling, and rash.[4] |
| Complications | Long term joint pain[5] |
| Usual onset | 2 to 14 days after exposure[6] |
| Duration | Usually less than a week[5] |
| Causes | Chikungunya virus spread by mosquitoes[6] |
| Diagnostic method | Blood test for viral RNA or antibodies[6] |
| Differential diagnosis | Dengue fever, Zika fever[6] |
| Prevention | Chikungunya vaccine, Mosquito control, avoidance of bites[7] |
| Treatment | Supportive care[6] |
| Prognosis | Risk of death ~ 1 in 1,000[7] |
| Frequency | > 1 million (2014)[6] |
Chikungunya is an infection caused by the chikungunya virus (CHIKV).[8][9][6] The disease was first identified in 1952 in Tanzania and named based on the Kimakonde words for "to become contorted".[6] Chikungunya has become a global health concern due to its rapid geographic expansion, recurrent outbreaks, the lack of effective antiviral treatments, and potential to cause high morbidity.[10] Chikungunya virus is closely related to O'nyong'nyong virus (ONNV), which shares similar genetic and clinical characteristics.[11]
Symptoms include fever and joint pain.[5] These typically occur two to twelve days after exposure.[6] Other symptoms may include headache, muscle pain, joint swelling, and a rash.[5] Symptoms usually improve within a week; however, occasionally the joint pain may last for months or years.[5][12] The risk of death is around 1 in 1,000.[7] The very young, old, and those with other health problems are at risk of more severe disease.[5]
The virus is spread between people by two species of mosquitos in the Aedes genus: Aedes albopictus and Aedes aegypti,[6] which mainly bite during the day,[13][14] particularly around dawn and in the late afternoon.[15] The virus may circulate within a number of animals, including birds and rodents.[6] Diagnosis is done by either testing the blood for viral RNA or antibodies to the virus.[6] The symptoms can be mistaken for those of dengue fever and Zika fever, which are spread by the same mosquitoes.[6] It is believed most people become immune after a single infection.[5]
The best means of prevention are overall mosquito control and the avoidance of bites in areas where the disease is common.[7] This may be partly achieved by decreasing mosquitoes' access to water, as well as the use of insect repellent and mosquito nets. Chikungunya vaccines have been approved for use in the United States[16] and in the European Union.[17][18][19]
The Chikungunya virus is widespread in tropical and subtropical regions where warm climates and abundant populations of its mosquito vectors (A. aegypti and A. albopictus) facilitate its transmission.[20] In 2014, more than a million suspected cases occurred globally.[6] While the disease is endemic in Africa and Asia, outbreaks have been reported in Europe and the Americas since the 2000s;[6] in 2014, an outbreak was reported in Florida in the continental United States. At the end of March, a severe outbreak of the Chikungunya virus (alongside dengue) was reported in Sri Lanka.[21] As of the second week of March 2025, there are 173 documented cases. Additionally, there have been 340 hospital admissions and 12 deaths linked to Chikungunya in 2025.[22]
- ^ "Definition of Chikungunya". www.merriam-webster.com. 8 September 2024. Retrieved 26 September 2024.
- ^ "Chikungunya in the United States". U.S. Centers for Disease Control and Prevention (CDC). 20 May 2024. Retrieved 26 September 2024.
- ^ "chikungunya". Oxford Learner's Dictionary. Oxford University Press. Archived from the original on 4 November 2014. Retrieved 4 November 2014.
- ^ "About Chikungunya". 17 May 2024.
- ^ a b c d e f g "Chikungunya Virus Symptoms, Diagnosis, & Treatment". U.S. Centers for Disease Control and Prevention (CDC). 6 April 2016. Archived from the original on 21 September 2016. Retrieved 26 September 2016.
- ^ a b c d e f g h i j k l m n o "Chikungunya Fact sheet". WHO. April 2016. Archived from the original on 27 September 2016. Retrieved 26 September 2016.
- ^ a b c d Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L (July 2013). "Chikungunya virus infection: an overview". The New Microbiologica. 36 (3): 211–27. PMID 23912863.
- ^ "Genus: Alphavirus". ICTV. Retrieved 26 September 2024.
- ^ Kril V, Aïqui-Reboul-Paviet O, Briant L, Amara A (29 September 2021). "New Insights into Chikungunya Virus Infection and Pathogenesis". Annual Review of Virology. 8 (1): 327–347. doi:10.1146/annurev-virology-091919-102021. ISSN 2327-056X. PMID 34255544.
- ^ Moizéis RN, Fernandes TA, Guedes PM, Pereira HW, Lanza DC, Azevedo JW, et al. (19 May 2018). "Chikungunya fever: a threat to global public health". Pathogens and Global Health. 112 (4): 182–194. doi:10.1080/20477724.2018.1478777. ISSN 2047-7724. PMC 6147074. PMID 29806537.
- ^ Yao Z, Ramachandran S, Huang S, Kim E, Jami-Alahmadi Y, Kaushal P, et al. (15 October 2024). "Interaction of chikungunya virus glycoproteins with macrophage factors controls virion production". The EMBO Journal. 43 (20): 4625–4655. doi:10.1038/s44318-024-00193-3. ISSN 0261-4189. PMC 11480453. PMID 39261662.
- ^ van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP (January 2017). "Long-term sequelae of chikungunya virus disease: A systematic review". Travel Medicine and Infectious Disease. 15: 8–22. doi:10.1016/j.tmaid.2017.01.004. PMID 28163198.
- ^ Paixão ES, Teixeira MG, Rodrigues LC (2018). "Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases". BMJ global health. 3 (Suppl 1): e000530. doi:10.1136/bmjgh-2017-000530. ISSN 2059-7908. PMC 5759716. PMID 29435366.
- ^ "Preventing Chikungunya". U.S. Centers for Disease Control and Prevention (CDC). 26 February 2016. Archived from the original on 15 September 2016. Retrieved 26 September 2016.
- ^ AFP (23 July 2025). "Outbreak of Chikungunya Virus Poses Global Risk, Warns WHO". ScienceAlert. Retrieved 24 July 2025.
- ^ "FDA Approval". U.S. Food and Drug Administration (FDA) (Press release). 9 November 2023. Archived from the original on 11 November 2023. Retrieved 11 November 2023.
- ^ "Ixchiq EPAR". European Medicines Agency (EMA). 30 May 2024. Archived from the original on 1 June 2024. Retrieved 1 June 2024.
- ^ "First vaccine to protect adults from Chikungunya". European Medicines Agency (EMA) (Press release). 31 May 2024. Retrieved 1 June 2024.
- ^ "Vimkunya EPAR". European Medicines Agency (EMA). 30 January 2025. Retrieved 16 February 2025.>
- ^ "Chikungunya fact sheet". www.who.int. Retrieved 5 March 2025.
- ^ "'Chikungunya' cases detected in Colombo and Gampaha, likely to spread in other regions". www.adaderana.lk. Retrieved 7 June 2025.
- ^ Herriman R (25 May 2025). "Sri Lanka chikungunya outbreak 2025". Outbreak News Today. Retrieved 7 June 2025.